BMS-707035 - CAS 729607-74-3
Catalog number:
729607-74-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C17H19FN4O5S
Molecular Weight:
410.42
COA:
Inquire
Targets:
HIV
Description:
BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 of 15 nM.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
MSDS:
Inquire
1.HIV-1 integrase inhibitors: an emerging clinical reality.
Dayam R1, Al-Mawsawi LQ, Neamati N. Drugs R D. 2007;8(3):155-68.
From the discovery of HIV-1 integrase (IN) inhibitors using enzyme-based assays in 1992, it has taken 15 years to achieve success in human clinical trials. Currently available antiretroviral drugs set high clinical standards in efficacy and long-term safety for upcoming novel HIV/AIDS therapeutic agents. The results from advanced stages of human clinical trials with IN inhibitors indicate a promising future for these compounds as a novel class of antiretroviral drugs. Success and failure of previously discovered antiretroviral drugs have taught us that there are no magic bullets in eradicating HIV. However, approval of drugs selectively targeting IN has long been awaited. There is once again a surge of interest in the field focusing on clinical development of IN inhibitors. Here, we summarise the current status of IN inhibitors under clinical development. These agents include S-1360, GSK-364735, L-870,810, L-870,812, MK-0518, GS-9137, L-900564, GS-9224, and BMS-707035.
2.Anti-infectives: clinical progress of HIV-1 integrase inhibitors.
Al-Mawsawi LQ1, Al-Safi RI, Neamati N. Expert Opin Emerg Drugs. 2008 Jun;13(2):213-25. doi: 10.1517/14728214.13.2.213 .
BACKGROUND: HIV-1 integrase (IN) represents a therapeutically advantageous viral target to treat HIV/AIDS in the clinic. Over a decade of progress in the field has resulted in IN inhibitor chemical classes that display specificity for strand transfer catalysis of the enzyme, thus blocking viral DNA integration into host cell nuclear DNA, an essential step for viral infectivity.
3.3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1.
Cotelle P1. Expert Opin Ther Pat. 2011 Nov;21(11):1799-804. doi: 10.1517/13543776.2011.624272. Epub 2011 Oct 6.
Since the discovery of raltegravir, the first FDA-approved integrase inhibitor, Merck and other pharmaceutical companies have continued their research programs in order to introduce novel molecules as second generation integrase inhibitors. Elvitegravir (Japan Tobacco/Gilead) and dolutegravir (Shionogi/GlaxoSmithKline) are in advanced stages of clinical development. Bristol-Myers Squibb has developed molecules leading to BMS-707035, which was stopped at the Phase II clinical trial stage. Herein is presented the last patent from this company where, in particular, new 3-hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones are synthesized and their biological properties given.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 544467-07-4 HIV-1 integrase inhibitor

HIV-1 integrase inhibitor
(CAS: 544467-07-4)

HIV-1 integrase inhibitor is uesful for anti-HIV, which can target HIV-1 integrase and depress the activity in the treatment of HIV infection, AIDS, and other s...

CAS 1051375-19-9 Dolutegravir sodium

Dolutegravir sodium
(CAS: 1051375-19-9)

Dolutegravir sodium salt is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G1...

CAS 202138-50-9 Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate
(CAS: 202138-50-9)

Tenofovir Disoproxil Fumarate belongs to a class of antiretroviral drugs, it inhibits the activity of HIV reverse transcriptase by competing with the natural su...

CAS 226700-81-8 Fosamprenavir Calcium Salt

Fosamprenavir Calcium Salt
(CAS: 226700-81-8)

HIV protease inhibitor; water soluble prodrug of amprenavir.

CAS 269055-15-4 Etravirine

Etravirine
(CAS: 269055-15-4)

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase i...

PD 135390
(CAS: 150351-31-8)

PD 135390 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections.

CAS 155213-67-5 Ritonavir

Ritonavir
(CAS: 155213-67-5)

Ritonavir is a very potent inhibitor of CYP3A4 mediated testosterone 6β-hydroxylation with mean Ki of 19 nM and also inhibits tolbutamide hydroxylation with IC5...

CAS 149845-06-7 Saquinavir Mesylate

Saquinavir Mesylate
(CAS: 149845-06-7)

Saquinavir is an HIV Protease Inhibitor used in antiretroviral therapy. It inhibits both HIV-1 and HIV-2 proteases. Studies have also looked at saquinavir as a ...

CGP 53820
(CAS: 149267-24-3)

CGP 53820 has been found to be a HIV-1 Protease pseudosymmetric inhibitor that could probably be effective in the treatment of HIV infections.

PD 134922
(CAS: 150351-30-7)

PD 134922 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections.

CAS 159989-65-8 Nelfinavir Mesylate

Nelfinavir Mesylate
(CAS: 159989-65-8)

Nelfinaviris a potent and orally bioavailable human immunodeficiency virus HIV-1 protease inhibitor.

CAS 376348-65-1 Maraviroc

Maraviroc
(CAS: 376348-65-1)

Selective CCR5 antagonist

CAS 143491-57-0 Emtricitabine

Emtricitabine
(CAS: 143491-57-0)

Emtricitabine moderately reduces hepatocyte proliferation independent of effects on mtDNA in HepG2 human hepatoma cells.

CAS 134678-17-4 Lamivudine

Lamivudine
(CAS: 134678-17-4)

Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS.

CAS 869901-69-9 MK-2048

MK-2048
(CAS: 869901-69-9)

MK-2048 is a second generation integrase inhibitor (IC50=2.6 nM). It can inhibits the HIV enzyme integrase 4 times longer than raltegravir.

D77
(CAS: 497836-10-9)

D77 is anti-HIV-1 inhibitor, which inhibits HIV-1(IIIB) replication (EC50=23.8 μM)

CAS 357263-13-9 BMS-378806

BMS-378806
(CAS: 357263-13-9)

BMS-378806 selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.

CAS 134624-73-0 Stavudine sodium

Stavudine sodium
(CAS: 134624-73-0)

Stavudine sodium is a dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. Stavudine sodium is an analog of thymi...

CAS 69655-05-6 Didanosine

Didanosine
(CAS: 69655-05-6)

Didanosine is a reverse transcriptase inhibitor with an IC50 of 0.49 μM.

CAS 147221-93-0 Delavirdine mesylate

Delavirdine mesylate
(CAS: 147221-93-0)

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of...

Chemical Structure

CAS 729607-74-3 BMS-707035

Quick Inquiry

Verification code

Featured Items